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Abstract
Objective: While respiratory symptoms in the first year
of  life are relatively well described for term infants,
data for preterm infants are scarce. We aimed to de-
scribe the burden of  respiratory disease in a group of
preterm infants with and without bronchopulmonary
dysplasia (BPD) and to assess the association of  respi-
ratory symptoms with perinatal, genetic and environ-
mental risk factors.
Methods: Single centre birth cohort study: prospective
recording of  perinatal risk factors and retrospective
assessment of  respiratory symptoms during the first
year of  life by standardised questionnaires. Main out-
come measures: Cough and wheeze (common symp-
toms), re-hospitalisation and need for inhalation thera-
py (severe outcomes). Patients: 126 preterms (median
gestational age 28.7 weeks; 78 with, 48 without BPD)
hospitalised at the University Children’s Hospital of
Bern, Switzerland 1999-2006.
Results: Cough occurred in 80%, wheeze in 44%, re-
hospitalisation in 25% and long term inhalation thera-
py in wheezers in 13% of  the preterm infants. Using
logistic regression, the main risk factor for common
symptoms was frequent contact with other children.
Severe outcomes were associated with maximal peak
inspiratory pressure, arterial cord blood pH, APGAR-
and CRIB-Score.
Conclusions: Cough in preterm infants is as common
as in term infants, whereas wheeze, inhalation therapy
and re-hospitalisations occur more often. Severe out-
comes are associated with perinatal risk factors.
Preterm infants who did not qualify for BPD accord-
ing to latest guidelines also showed a significant bur-
den of  respiratory disease in the first year of  life. 
Key words: premature birth, cough, wheeze, risk fac-
tors, bronchopulmonary dysplasia.
INTRODUCTION
Respiratory problems are major consequences of  pre-
maturity, however the heterogeneity of  respiratory se-
quelae and varying definitions have made a systematic
assessment difficult. Northway et al. were the first 
to describe them as “bronchopulmonary dysplasia”
(BPD) [1]. The definition of  BPD has been revised
several times as with advances in perinatal treatment
the clinical and pathomorphological patterns have
changed. The most recent consensus definition of
2001 groups severity of  “new BPD” into mild, moder-
ate and severe according to gestational age and dura-
tion of  supplementary oxygen [2]. Recently a large
American cohort study used this definition to assess
its usefulness for predicting respiratory morbidity in
the first year of  life [3]. The authors found a high sen-
sitivity using this BPD classification, but specificity
was poor: 30% of  preterm infants had severe respira-
tory problems without qualifying for BPD. Since in-
formation on additional risk factors is lacking, it re-
mains unclear whether the identification of  risk fac-
tors could help improving prediction of  respiratory
morbidity after preterm birth. 
Incidence and severity of  respiratory symptoms in
the first year of  life are relatively well described in
term born infants. One study reported persistent
cough to occur in 56% and wheeze in 45% of  term-
born infants in the USA [4]. Another study, conducted
in Australia, found 77% of  the infants coughing and
27% wheezing during the first year of  life [5]. In a re-
cent prospective study from our group assessing respi-
ratory morbidity in a birth cohort of  term-born in-
fants, any cough occurred in 93% and wheeze in 21%
of  the infants during the first year of  life [6]. Frequen-
cy of  symptoms was associated with male sex, higher
birthweight, pre- and postnatal smoke exposure and
day care or older siblings. Only 3 of  all 195 infants
(1.5%) had to be hospitalised for respiratory problems
in their first year of  life [6]. 
In contrast to term infants, few data are available on
respiratory morbidity in preterm infants. There are
studies on outcome and associated risk factors from
the pre-surfactant era [7], but data including children
with the “new” form of  BPD are scarce. Most of
these studies focused on severe outcomes [3] and only
few have determined risk factors [8] for pulmonary se-
quelae for which preterm infants show a predisposi-
tion [9-11]. 
The aim of  the present study was to describe fre-
quency and spectrum of  respiratory symptoms during
the first year of  life in a contemporary population of
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preterm infants with and without BPD and to identify
environmental and perinatal risk factors associated
with common and severe respiratory symptoms.
METHODS
STUDY DESIGN
Preterm infants (gestational age <37 wks), born be-
tween July 1999 and June 2005 and hospitalised at the
University Hospital of Bern, Switzerland,were prospec-
tively recruited during a consultation of  a paediatric
pulmonologist before discharge. Perinatal data were
routinely recorded using the institutional neonatology
database (NEODAT 4.10, Tübingen, Germany). After
the first year of  life, a standardised questionnaire was
sent to the parents to assess respiratory morbidity dur-
ing the first year after discharge and ongoing environ-
mental exposures. 
SUBJECTS
We approached preterm infants independent of  their
birthweight with 168 being recruited for the study.
More parents of  infants with lower birthweight agreed
to participate resulting in a study population of  123
(72%), 67 (40 %) and 3 (2%)  preterms with birth-
weights below 1500g,  below 1000g and below 500g,
respectively. 
Based on the ATS definition of  BPD, we cate-
gorised preterm infants into healthy, mild, moderate
and severe BPD, respectively [2]. BPD was defined as
supplemental oxygen requirement for at least 28 days.
Time point of  assessment for BPD severity was at 36
weeks post-menstrual age (PMA) or at discharge
(whichever occurred first) in infants born at less than
32 weeks of  gestation, and at day 56 of  life in infants
born with at least 32 weeks of  gestation. Mild BPD
was defined as breathing room air, moderate BPD as
requiring less than 30% supplemental oxygen and se-
vere BPD as the need for more than 30% of  oxygen.
The standardised internal hospital guidelines were ap-
plied to determine the exact amount of  oxygen need-
ed (aiming for 92% or more oxygen saturation allow-
ing dips to 86%) and BPD classification was verified
in each case by review of  the medical records. The
ethics committee of  the canton of  Bern approved the
study protocol and written informed consent was ob-
tained from the parents.
ASSESSMENT OF PERINATAL DATA
The data routinely entered in the institutional database
(NEODAT) are given in Table 1 and 3.
DEFINITION OF RESPIRATORY MORBIDITY
(OUTCOMES) 
Respiratory morbidity was assessed by a standardised
questionnaire using modified questions from the In-
ternational Study on Asthma and Allergies in Child-
hood (ISAAC) [12, 13] to the parents. The main out-
comes were categorised into common and severe:
Cough with cold (“did your child cough during times
with a cold?”) and wheeze were considered as com-
mon respiratory symptoms, whereas re-hospitalisation
for pulmonary reasons (excluding readmissions for di-
agnostic purposes) or long-term inhalation therapy
(longer than four weeks) in wheezing infants were de-
fined as severe outcomes [3, 14]. In addition the sub-
jective burden of  disease and the need for consulta-
tions at any healthcare institution were assessed by the
questionnaire. 
DEFINITION OF RISK FACTORS
Potential risk factors were grouped into 3 categories: 
A) Perinatal risk factors: Factors that have previous-
ly been described as either influencing the outcome of
preterm infants or having an effect on the occurrence
of  BPD such as gestational age, sex, birthweight, ma-
ternal chorioamnionitis (histopathologically con-
firmed), PDA (patent ductus arteriosus) when of  he-
modynamic relevance in echocardiography, peak inspi-
ratory pressure (PIP) during mechanical ventilation
and antenatal steroids [15-18].
B) Factors of  postnatal adaptation: Perinatal para-
meters reflecting the adaptation and initial condition
of  the newborn, such as APGAR score, arterial cord-
blood pH-value [19] and CRIB score. 
C) Environmental and sociodemographic expo-
sures: Known risk factors for respiratory symptoms in
term infants including day care or older siblings, histo-
ry of  parental atopic disease and smoke exposure [6,
20]. 
STATISTICAL ANALYSIS
We used descriptive statistics to illustrate the occur-
rence and parental perception of  respiratory morbidi-
ty. Second, to identify possible risk factors, we
grouped all outcome parameters into binary categories
and calculated the association between outcomes and
risk factors using logistic regression analysis. All listed
risk factors were entered into the model one by one as
explanatory factors; continuous variables were cen-
tred. Results are given as odds ratios with confidence
intervals and exact p-values. Due to the small sample
size and a strong co-linearity between many of  the pa-
rameters, only univariable analysis was performed.
Sensitivity analysis stratifying for gestational age, sex,
birthweight and age at reply of  questionnaire con-
firmed the main results. Data analyses were performed
using STATA® version 8.2 for Windows (STATA
Corporation, College Station, TX, USA).
RESULTS
SUBJECTS
We primarily recruited 168 infants and received 126
(75%) completed questionnaires back. Median gesta-
tional age was 28.7 weeks (range 23.9-36.1), median
birthweight was 1070g (range 420-2980), 71 (56%) in-
fants were male and 55 (44%) female; 78 (62%) ful-
filled the criteria of  new BPD and 48 (38%) were clas-
sified as having no BPD. 
Of  all questionnaires, 65% were filled in by the par-
ents when their child was 1-3 years, 35% when the
child was older. A sensitivity analysis showed no dif-
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ferences between those two groups. Descriptive data
of  the study group are given in Table 1.
BURDEN OF RESPIRATORY MORBIDITY
The occurrence of  common respiratory symptoms
(e.g. cough and wheeze) and severe outcomes (e.g. re-
hospitalisation and long term inhalation therapy) is
shown in Table 2, burden of  disease is illustrated in
Figure 1. Common respiratory symptoms occurred with
high frequency: 80% (95%-CI 71-86%) of  the infants
had cough and 44% (95%-CI 36-54%) wheeze.
Severe outcomes were less frequent: re-hospitalisa-
tion occurred in 25% (95%-CI 17-33%) of  all chil-
dren, and long term inhalation because of  wheezing in
13% (95%-CI 7-20%) of  the infants. Parental state-
ment of  re-hospitalisation was very consistent with
medical records.
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Table 2. Respiratory outcome in the first year after discharge.
total no BPD BPD
BPD vs
no BPD
Variables n = 126 n = 48 n = 78
abs % CI % abs % CI % abs % CI % p-value
Common outcomes
Cough 100 79 71 - 86 40 83 70 - 93 60 77 66 - 86 0.50
Wheezinga 56 44 36 - 54 23 48 33 - 63 33 43 31 - 54 0.58
Severe outcomes
Re-hospitalisationb 31 25 17 - 33 11 23 12 - 37 20 26 16 - 37 0.83
Inhalation therapyc 16 13 7 - 20 3 6 1 - 17 13 17 9 - 27 0.25
Numbers are given as absolute count (abs) as well as percentage and 95% Confidence interval (CI).
a Data not available for 2 infants
bRehospitalisation for respiratory reasons (excluding admissions for diagnostic purposes)
c Inhalation therapy because of prolonged wheezing with corticosteroids, beta-mimetika or both, for more than four weeks.
Table 1. Characteristics of the study population of preterm infants (n = 126).
Characteristics n % a
Bronchopulmonary dysplasia (BPD) 78 62
mild BPD 28 36
moderate BPD 36 46
severe BPD 14 18
Gestational age in weeks (median/range) 28.71 23.9 - 36.1
Male sex 71 56
Birthweight in g (median/range) 1070 420-2980
Chorioamnionitis 42 37
Patent ductus arteriosus 29 23
Prenatal steroids 102 81
Surfactant therapy 48 38
Mechanical ventilation 66 52
Days of mech. ventilation (median/range) 1 0-63
CPAP b 113 90
Days on oxygen therapy (median/range) 42 0-385
Days of initial hospital stay (median/range) 70 7-141
Contact to other children c 75 61
Maternal smoking in pregnancy d 13 10
Maternal atopy e 20 16
a Data are given as number (percentage) if not indicated otherwise.
b CPAP = continuous positive airway pressure breathing support
c Contact to other children = having siblings or going to a nursery care institution regularly 
d Assessed by parental questionnaire
e Maternal atopy = mother has asthma and/or allergic rhinitis and/or atopic dermatitis
While frequency of  common symptoms did not dif-
fer between children with and without BPD, there was
a trend towards more inhalation therapy in the BPD
group.
Of  the patients included 9 (7%)  had RSV vaccina-
tion; 8 (6%) children suffered from severe RSV infec-
tion they needed to be hospitalised for, two of  those
had been vaccinated before.
PARENTAL PERCEPTION OF RESPIRATORY MORBIDITY
In 53 families (45%) parents considered their infant to
cough as much as a healthy term infant, 34 (29%) be-
lieved their infant to cough more often and 30 (26%)
less often than healthy infants. 
Slightly more than half  of  the parents (n=65, 55%)
reported that they consulted the community paediatri-
cian in an emergency situation during the first year of
life, 43 (73%) of  those once or twice and 16 (27%)
more often, up to a maximum of  10 times. 
DETERMINANTS OF RESPIRATORY OUTCOME
Table 3 shows associations between analysed risk fac-
tors and respiratory morbidity. 
Common symptoms
Common respiratory symptoms were mainly associat-
ed with environmental exposures. Children who were
exposed to other children had a four-fold risk of  hav-
ing common symptoms (OR 4.7; 95%-CI 1.8-12.6,
p=0.002). While there was no difference between the
outcomes cough and wheeze for most of  the risk fac-
tors, maternal smoking during pregnancy was associat-
ed mainly with wheeze (OR 4.7; 95%-CI 1.2-18.1, p =
0.024) and contact with other children mainly with
cough in the first year of  life (OR 4.1; 95%-CI 1.6-
10.5, p=0.004).
Severe outcomes
Contrary to those for common symptoms, risk factors
for severe outcomes were mainly parameters repre-
senting perinatal adaptation. A significant association
with both re-hospitalisation and inhalation therapy
was found for high peak inspiratory pressure, low arte-
rial cord blood pH, low APGAR-score and low CRIB-
score, as shown in Table 3. Low arterial cord blood
pH (<7.15) was associated with a 4.4-fold (95%-CI
1.4-13.6, p=0.011) increased likelihood of  severe
symptoms.
No association was found between any of  the in-
vestigated outcomes and need for intubation, surfac-
tant therapy, parental educational status or parental
smoking in the first year. 
DISCUSSION
SUMMARY
In our cohort of  preterm infants with and without
BPD, respiratory symptoms were frequent during in-
fancy: cough with cold was reported for 80% and
wheeze for 45% of  infants, respectively. More severe
symptoms were less common, with re-hospitalisation
for respiratory reasons occurring in 25% of  infants
and 13% of  infants needing long-term inhalation ther-
apy of  more than four weeks because of  wheezing.
Risk factors differed between common and severe
symptoms. While common symptoms were associated
with environmental factors such as contact to other
children, severe symptoms were associated with risk
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Fig. 1. Burden of common and severe
symptoms in pretem (n = 126) and term
(n = 195).
factors reflecting perinatal adaptation, such as APGAR-
score, CRIB-score and cord blood pH.
RESPIRATORY MORBIDITY
Data on prevalence of  cough and wheeze in preterm
infants from the post-surfactant era are rare: Gree-
nough et al. reported that 51% of  preterm infants
born at less than 29 weeks of  gestation suffered from
cough and 42% from wheeze during the first year of
life [8]. Vrijland et al. described cough to occur in
97% and wheeze in 39% of  preterm infants [21]. In
an important study from the presurfactant era 53 to
65% of  the infants had cough or wheeze during the
first 6 months of  life [22]. Our results are well in line
with these reports. Interestingly, despite differences in
data assessment, age range, observational periods and
countries, the high prevalence of  wheeze and even
higher prevalence of  cough seems to be a consistent
finding among studies.
Re-hospitalisation rates of  preterm infants in the
first 1-2 years are reported in the literature to occur in
14% [23] to 38% [24] of  preterm infants with and
without BPD, well comparable to our results and
known to be dependent on gestational age and differ-
ences in patient management [24]. 
To our knowledge there are no data available com-
paring respiratory morbidity between term- and
preterm-born infants from the same area and time pe-
riod. We have recently reported on respiratory morbid-
ity and risk factors in a large unselected prospective co-
hort of  term-born infants with weekly assessment of
respiratory symptoms [6]. Recruitment area and time
period were the same as in the present study. In these
healthy term-born infants, the overall prevalence of
cough was comparable (93%, compared to 79% in
preterm children), whereas wheeze occurred less often
in term children (21%) than in preterm children (44%).
This is quite remarkable, considering that the method
of  data collection used for term infants (weekly phone
calls) is expected to be more sensitive than the method
used for preterm children (retrospective questionnaire)
[12]. Hospitalisation due to respiratory reasons in the
first year of  life was reported for 25% of  preterm, but
only for 1.5% of  term-born infants [6].
RISK FACTORS
Common symptoms were mainly associated with 
environmental exposures, in accordance with findings
by Greenough et al. who reported that male sex, 
duration of  oxygen therapy, older siblings and socioe-
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Table 3. Risk factors and their association with common and severe respiratory outcomes  in all subjects (n = 126).
Risk factors Common outcomes Severe outcomes
n = 101 n = 37
OR CI p-value OR CI p-value
BPDa 0.57  (0.22-1.49)  0.249 1.20  (0.54-2.66)  0.659
Known risk factors for BPD
Gestational age, per week 1.04  (0.89-1.22)  0.605 0.94  (0.82-1.08)  0.375
Male sex 1.25  (0.52-3.00)  0.625 1.02  (0.47-2.22)  0.953
Birthweight, per kg 1.36  (0.56-3.29)  0.493 0.70  (0.32-1.51)  0.362
Chorioamnionitisb 1.58  (0.56-4.44)  0.387 1.55  (0.68-3.52)  0.295
PDAc 1.65  (0.51-5.32)  0.402 0.56  (0.21-1.52)  0.253
PIPd 1.10  (0.92-1.33)  0.292 1.24  (1.05-1.47)  0.012
Factors of perinatal adaption
Cord blood pHe 1.98  (0.41-9.48)  0.393 4.37  (1.4-13.61)  0.011
APGAR score at 10 min.f 1.05  (0.74-1.49)  0.783 1.55  (1.14-2.12)  0.006
CRIB-score 0.93 (0.82-1.05)  0.232 1.14  (1.01-1.28)  0.024
Environmental risk factors
Contact to other childreng 4.71 (1.77-12.56)  0.002 1.30  (0.59-2.90)  0.516
Maternal atopy 1.52  (0.41-5.66)  0.532 0.82  (0.27-2.46)  0.727
Smoking in pregnancy 1.41  (0.29-6.79)  0.672 1.58  (0.48-5.20)  0.450
In the table are shown: Odds ratio (OR), calculated by univariable logistic regression, defining the increased odds of having the
respective outcome with the respective risk factor present; 95% Confidence interval (CI) and p-value. 
a BPD was defined as in the consensus guidelines (2)
b Chorioamnionitis was verified by histological findings of the placenta
c PDA = haemodynamic relevant patent ductus arteriosus
d PIP = maximum peak inspiratory pressure
e Cord blood pH = arterial chord blood pH: 1 defined as <7.15 and 0 defined as > 7.15
f comparable results were obtained for APGAR-scores at 1 and 5 minutes 
g Contact to other children = having siblings or going to a nursery care institution regularly
conomic status were associated with respiratory
symptoms in the first year of  life in preterms born
before 29 weeks of  gestation [8]. Our results show
that this holds also for preterms born after 29 weeks
of  gestation. In contrast, severe respiratory symptoms
were stronger associated with parameters reflecting
perinatal adaptation. APGAR- and CRIB score have
been described to predict outcome of  preterm infants
[19] and it has been shown that higher PIP is associat-
ed with decreased survival rates [17]. 
Surprisingly, BPD was not correlated with severe
respiratory morbidity in the present study, although a
trend was found for severe outcomes. The association
with BPD severity and long-term respiratory morbidi-
ty has remained controversial and comparison of
these studies is difficult due to varying BPD defini-
tions [25-28]. Ehrenkranz et al. found a reasonable as-
sociation between severe outcomes and the “new
BPD” classification [3]. One possible explanation
might be differing neonatal treatment strategies be-
tween Europe and the USA. Premature infants in our
cohort had shorter mechanical ventilation and early
nasal CPAP therapy. In contrast, different guidelines
lead to intubation and longer duration of  mechanical
ventilation in the USA [29]. 
Gestational age was not associated with respiratory
symptoms. These results are again different than
American results [30] but in line with the London co-
hort [8]. This might reflect the different picture of
“new” BPD, which is indeed known not to be exclu-
sively dependent on gestational age [8]. 
While risk factors for common respiratory symp-
toms were similar for premature and term neonates,
severe outcomes in preterms were related to perinatal
factors. Furthermore, other factors found to be asso-
ciated with respiratory morbidity in the term-born co-
hort, such as sex, birthweight and maternal atopy
were not associated with respiratory symptoms in
preterms. We assume that the influence of  these fac-
tors is masked by stronger effects induced by prema-
turity and the related developmental changes of  the
immune system as well as of  lung and airway growth.
It is e.g. known that boys have smaller airways at birth
and thus more respiratory problems than girls [31],
but this gender difference is less prominent in prema-
ture infants [32] and likely to be overruled by other
factors.
PARENTAL PERCEPTION
One third of  the parents may overestimate the com-
mon respiratory morbidity of  their preterm born chil-
dren when comparing to term infants and consult
their Paediatrician early. Thus parental counselling at
discharge related to common in respect to severe res-
piratory morbidity may help to improve the burden of
the health care system.
METHODOLOGICAL ISSUES
There are limitations of  our study. It is a retrospective
survey, with questionnaires sent to the parents at dif-
ferent ages of  their children. This may lead to recall
bias, however similar results after stratification by age
at reply of  questionnaires makes this unlikely. Further-
more it has been shown that questions on respiratory
symptoms have a good repeatability, supporting validi-
ty of  our findings [13, 33]. Another possible bias is the
fact that we only included children who underwent in-
fant lung function which makes generalisation of  the
results more difficult. Due to rather low numbers we
were not able to perform multivariable analyses. The
relatively small sample size might also explain why pa-
rameters like gestational age or chorioamnionitis were
only weakly associated with respiratory morbidity [3].
In addition, causal pathways are difficult to model in
the analysis, because many of  the examined parame-
ters may function either as independent risk factor or
alternatively be a consequence of  another risk factor,
therefore lying in the causal pathway. For instance high
peak inspiratory pressure can injure the premature
lung by itself, on the other hand, ventilation with high
pressures could have been made necessary because of
an injured premature lung. All these factors are impor-
tant to bear in mind when interpreting the results. To
validate our findings and clearly disentangle all these
interactions, larger studies should be conducted in fu-
ture.
RELEVANCE
From a clinical point of  view, the identification of  risk
factors may help to promote further individualized
treatment and prevent long-term sequelae in preterm
infants. The risk factors for respiratory diseases during
infancy should be considered as an important part of
planning discharge and follow-up of  high-risk prema-
ture infants. For instance, in line with other, mainly
European studies, we can support the hypothesis that
gentle breathing support results in less frequent BPD
rates as well as in less respiratory symptoms even in
very young preterm infants [34].
From a public health point of  view, prenatal birth is
the commencement of  a relevant burden of  disease
for patients, parents [35] and the health care system.
This includes doctor visits apart from routine check-
ups, re-hospitalisations as well as psychological and fi-
nancial burden of  long-term medication. This burden
is strongly dependent on the correct identification of
those infants subject to appropriate treatment. In
Switzerland, decisions on medication and reimburse-
ment of  health care costs are strongly influenced by
the current BPD definition. For instance, vaccination
against respiratory syncytial virus is only recommend-
ed and paid in preterm infants with severe BPD, it can
be considered for patients with moderate BPD and is
not recommended for patients with mild BPD. How-
ever, our data and other studies show that prematurity
rather than BPD definitions and other risk factors de-
fine respiratory morbidity in these preterm infants in
the first year of  life. Due to these aspects current
health care policies need urgent reconsideration.
CONCLUSION
The results of  this study indicate that premature in-
fants are subject to a high incidence of  respiratory
morbidity even after hospital discharge imposing a rel-
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evant burden of  disease for patients, parents and the
health care system. By describing respiratory morbidi-
ty in the first year of  life in these preterm infants and
assessing associated risk factors, our study will con-
tribute to the identification of  patients with the high-
est risk for later respiratory morbidity. Growing
knowledge on the pathophysiology as well as changes
in perinatal management will however lead to continu-
ous changes of  this picture. As more patients with the
“new” form of  BPD will reach older age, larger stud-
ies with longer follow-up times and measurement of
subtle lung function indices will be needed to assess
the long-term outcome of  these children.
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